These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 30739069

  • 1. Evaluation of p16/Ki-67 dual staining in the detection of cervical precancer and cancer in China.
    Zhang SK, Jia MM, Zhao DM, Wu ZN, Guo Z, Liu YL, Guo PP, Chen Q, Cao XQ, Liu SZ, Chen W, Sun XB.
    Cancer Epidemiol; 2019 Apr; 59():123-128. PubMed ID: 30739069
    [Abstract] [Full Text] [Related]

  • 2. Dual staining for p16/Ki-67 to detect high-grade cervical lesions: Results from the Screening Triage Ascertaining Intraepithelial Neoplasia by Immunostain Testing study.
    El-Zein M, Gotlieb W, Gilbert L, Hemmings R, Behr MA, Franco EL, STAIN-IT Study Group.
    Int J Cancer; 2021 Jan 15; 148(2):492-501. PubMed ID: 32781481
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of p16/Ki-67 dual staining in detection of cervical precancer and cancers: a multicenter study in China.
    Yu LL, Chen W, Lei XQ, Qin Y, Wu ZN, Pan QJ, Zhang X, Chang BF, Zhang SK, Guo HQ, Qiao YL.
    Oncotarget; 2016 Apr 19; 7(16):21181-9. PubMed ID: 27029033
    [Abstract] [Full Text] [Related]

  • 4. Triage of LSIL/ASC-US with p16/Ki-67 dual staining and human papillomavirus testing: a 2-year prospective study.
    White C, Bakhiet S, Bates M, Keegan H, Pilkington L, Ruttle C, Sharp L, O' Toole S, Fitzpatrick M, Flannelly G, O' Leary JJ, Martin CM.
    Cytopathology; 2016 Aug 19; 27(4):269-76. PubMed ID: 26932360
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Five-Year Risk of Cervical Precancer Following p16/Ki-67 Dual-Stain Triage of HPV-Positive Women.
    Clarke MA, Cheung LC, Castle PE, Schiffman M, Tokugawa D, Poitras N, Lorey T, Kinney W, Wentzensen N.
    JAMA Oncol; 2019 Feb 01; 5(2):181-186. PubMed ID: 30325982
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Performance of p16/Ki-67 immunostaining to detect cervical cancer precursors in a colposcopy referral population.
    Wentzensen N, Schwartz L, Zuna RE, Smith K, Mathews C, Gold MA, Allen RA, Zhang R, Dunn ST, Walker JL, Schiffman M.
    Clin Cancer Res; 2012 Aug 01; 18(15):4154-62. PubMed ID: 22675168
    [Abstract] [Full Text] [Related]

  • 9. Meta-analysis of the accuracy of p16 or p16/Ki-67 immunocytochemistry versus HPV testing for the detection of CIN2+/CIN3+ in triage of women with minor abnormal cytology.
    Peeters E, Wentzensen N, Bergeron C, Arbyn M.
    Cancer Cytopathol; 2019 Mar 01; 127(3):169-180. PubMed ID: 30811902
    [Abstract] [Full Text] [Related]

  • 10. The Accuracy of p16/Ki-67 and HPV Test in the Detection of CIN2/3 in Women Diagnosed with ASC-US or LSIL.
    Possati-Resende JC, Fregnani JH, Kerr LM, Mauad EC, Longatto-Filho A, Scapulatempo-Neto C.
    PLoS One; 2015 Mar 01; 10(7):e0134445. PubMed ID: 26230097
    [Abstract] [Full Text] [Related]

  • 11. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
    Gustinucci D, Passamonti B, Cesarini E, Butera D, Palmieri EA, Bulletti S, Carlani A, Staiano M, D'Amico MR, D'Angelo V, Di Dato E, Martinelli N, Malaspina M, Spita N, Tintori B, Fulciniti F.
    Acta Cytol; 2012 Mar 01; 56(5):506-14. PubMed ID: 23075891
    [Abstract] [Full Text] [Related]

  • 12. Triaging HPV-positive women with p16/Ki-67 dual-stained cytology: Results from a sub-study nested into the ATHENA trial.
    Wright TC, Behrens CM, Ranger-Moore J, Rehm S, Sharma A, Stoler MH, Ridder R.
    Gynecol Oncol; 2017 Jan 01; 144(1):51-56. PubMed ID: 28094038
    [Abstract] [Full Text] [Related]

  • 13. p16/Ki-67 Dual Staining Is a Reliable Biomarker for Risk Stratification for Patients With Borderline/Mild Cytology in Cervical Cancer Screening.
    Magkana M, Mentzelopoulou P, Magkana E, Pampanos A, Vrachnis N, Kalafati E, Daskalakis G, Domali E, Thomakos N, Rodolakis A, Anagnou NP, Pappa KI.
    Anticancer Res; 2022 May 01; 42(5):2599-2606. PubMed ID: 35489732
    [Abstract] [Full Text] [Related]

  • 14. Good performance of p16/Ki-67 dual-stain cytology for detection and post-treatment surveillance of high-grade CIN/VAIN in a prospective, cross-sectional study.
    Liu W, Gong J, Xu H, Zhang D, Xia N, Li H, Song K, Lv T, Chen Y, Diao Y, Jao J, Dai S, Zhao P, Yao Q.
    Diagn Cytopathol; 2020 Jul 01; 48(7):635-644. PubMed ID: 32275355
    [Abstract] [Full Text] [Related]

  • 15. Screening for cervical cancer precursors with p16/Ki-67 dual-stained cytology: results of the PALMS study.
    Ikenberg H, Bergeron C, Schmidt D, Griesser H, Alameda F, Angeloni C, Bogers J, Dachez R, Denton K, Hariri J, Keller T, von Knebel Doeberitz M, Neumann HH, Puig-Tintore LM, Sideri M, Rehm S, Ridder R, PALMS Study Group.
    J Natl Cancer Inst; 2013 Oct 16; 105(20):1550-7. PubMed ID: 24096620
    [Abstract] [Full Text] [Related]

  • 16. Defining Optimal Triage Strategies for hrHPV Screen-Positive Women-An Evaluation of HPV 16/18 Genotyping, Cytology, and p16/Ki-67 Cytoimmunochemistry.
    Stanczuk GA, Baxter GJ, Currie H, Forson W, Lawrence JR, Cuschieri K, Wilson A, Patterson L, Govan L, Black J, Palmer T, Arbyn M.
    Cancer Epidemiol Biomarkers Prev; 2017 Nov 16; 26(11):1629-1635. PubMed ID: 28887297
    [Abstract] [Full Text] [Related]

  • 17. Triaging borderline/mild dyskaryotic Pap cytology with p16/Ki-67 dual-stained cytology testing: cross-sectional and longitudinal outcome study.
    Uijterwaal MH, Witte BI, Van Kemenade FJ, Rijkaart D, Ridder R, Berkhof J, Balfoort-van der Meij GA, Bleeker MC, Snijders PJ, Meijer CJ.
    Br J Cancer; 2014 Mar 18; 110(6):1579-86. PubMed ID: 24518601
    [Abstract] [Full Text] [Related]

  • 18. p16/Ki-67 dual staining has a better accuracy than human papillomavirus (HPV) testing in women with abnormal cytology under 30 years old.
    Pirtea L, Secosan C, Margan M, Moleriu L, Balint O, Grigoras D, Sas I, Horhat F, Jianu A, Ilina R.
    Bosn J Basic Med Sci; 2019 Nov 08; 19(4):336-341. PubMed ID: 29924960
    [Abstract] [Full Text] [Related]

  • 19. p16/Ki67 dual stain triage versus cytology in primary human papillomavirus-based cervical cancer screening with limited genotyping.
    Trzeszcz M, Mazurec M, Jach R, Mazurec K, Kotkowska-Szeps I, Kania M, Wantuchowicz M, Wasowska J, Duczek-Polakiewicz M, Rozmus P, Streb J, Halon A.
    J Med Virol; 2023 Nov 08; 95(11):e29271. PubMed ID: 38009626
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of p16/Ki-67 dual-stained cytology as triage test for high-risk human papillomavirus-positive women.
    Ebisch RM, van der Horst J, Hermsen M, Rijstenberg LL, Vedder JE, Bulten J, Bosgraaf RP, Verhoef VM, Heideman DA, Snijders PJ, Meijer CJ, van Kemenade FJ, Massuger LF, Melchers WJ, Bekkers RL, Siebers AG.
    Mod Pathol; 2017 Jul 08; 30(7):1021-1031. PubMed ID: 28304400
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.